NuCana plc
(NASDAQ:NCNA)
$0.42
0.01 (1.94%)
At Close: 4:00 PM
NuCana Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
NuCana Stock Price Today
NuCana plc (NCNA) stock declined over -8.11% intraday to trade at $0.4227 a share on NASDAQ. The stock opened with a gain of 34.15% at $0.55 and touched an intraday high of $0.55, rising 3.10% against the last close of $0.41. The NuCana plc in stock market went to a low of $0.45 during the session.
NuCana Stock Snapshot
$0.41
Prev. Close
21.96 Million
Market Cap
$0.45
Day Low
$0.55
Open
N/A
Number of Shares
$0.55
Day High
N/A
P/E ratio
-0.82
EPS (TTM)
0.34
Cash Flow per Share
N/A
Free Float in %
0.42
Book Value
141320.00
Volume
NuCana Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.02
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.
Peers
Frequently Asked Questions
What is the current NuCana plc (NCNA) stock price?
NuCana plc (NASDAQ: NCNA) stock price is $0.42 in the last trading session. During the trading session, NCNA stock reached the peak price of $0.55 while $0.45 was the lowest point it dropped to. The percentage change in NCNA stock occurred in the recent session was -8.11% while the dollar amount for the price change in NCNA stock was -$0.04.
NCNA's industry and sector of operation?
The NASDAQ listed NCNA is part of Biotechnology industry that operates in the broader Healthcare sector. NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology.
Who are the executives of NCNA?
Mr. Hugh Stephen Griffith
Founder, Chief Executive Officer & Executive Director
Ms. Elisabeth Oelmann
Senior Vice President of Medical & Clinical Devel.
Mr. Hugh Stephen Griffith
Founder, CEO & Exec. Director
Ms. Theresa Bruce
Sr. VP of Clinical Operations
How NCNA did perform over past 52-week?
NCNA's closing price is 0.37% higher than its 52-week low of $0.4501 where as its distance from 52-week high of $1.75 is -0.68%.
How many employees does NCNA have?
Number of NCNA employees currently stands at N/A. NCNA operates from 3 Lochside Way, Edinburgh, EH12 9DT, GB.
Link for NCNA official website?
Official Website of NCNA is: https://www.nucana.com
How do I contact NCNA?
NCNA could be contacted at phone #44 13 1357 1111 and can also be accessed through its website. NCNA operates from 3 Lochside Way, Edinburgh, EH12 9DT, GB.
How many shares of NCNA are traded daily?
NCNA stock volume for the day was 141320.00 shares. The average number of NCNA shares traded daily for last 3 months was 71.7 Thousands.
What is the market cap of NCNA currently?
The market value of NCNA currently stands at $21.96 Million with its latest stock price at $0.42 and N/A of its shares outstanding.